UK Markets close in 6 hrs 52 mins

Insights on the Automated and Closed Cell Therapy Processing Systems Global Market to 2028 - by Workflow, Type, Scale, and Segment Forecasts -

·4-min read

DUBLIN, November 30, 2021--(BUSINESS WIRE)--The "Automated and Closed Cell Therapy Processing Systems Market Size, Share & Trends Analysis Report by Workflow (Separation, Expansion), by Type (Non-stem Cell, Stem Cell), by Scale, and Segment Forecasts, 2021 - 2028" report has been added to's offering.

The global automated and closed cell therapy processing systems market is expected to reach USD 2.94 billion by 2028, registering a CAGR of 21.7% over the forecast period. Market players are making significant investments to introduce an automated process system as a viable strategy to accelerate their cell therapy product development process, thereby driving market growth.

The expansion of GMP manufacturing facilities further supports the implementation of automated processes for commercial operations. In addition, the wide application scope of single-use disposable tubing sets and bags also facilitates automated processing of therapy R&D. Moreover, key entities are undertaking strategies for effective implementation of automation technology in manufacturing labs resulting in lucrative revenue growth.

The rapid growth in the cases of COVID-19 is anticipated to play a vital role in the market growth. The pandemic has led to an increased focus on automation technologies. Moreover, the companies emphasized raising funds with an aim to develop advanced therapies and regenerative medicines to fight against COVID-19. Industry players are also concentrating on the development of new therapies, such as stem cell therapy, natural killer cell therapy, exosomes, and others.

Companies Mentioned

  • Biospherix, Ltd.

  • Cellares Inc.

  • Cytiva (Danaher Corporation)

  • Fresenius Kabi

  • Lonza

  • Miltenyi Biotec

  • Sartorius Ag

  • Terumo Corporation

  • Thermo Fisher Scientific, Inc.

  • Thermogenesis Holdings, Inc.

Automated And Closed Cell Therapy Processing Systems Market Report Highlights

  • The cell expansion workflow segment accounted for the maximum revenue share of the global market in 2020. An increasing focus on achieving high output yield has resulted in the high revenue share of the segment

  • The cell separation workflow segment is estimated to register the fastest CAGR during the forecast period due to an increasing number of stem cell therapy R&D programs

  • Automated apheresis and cryopreservation workflow are also expected to register considerable growth rates over the forecast period due to the growing emphasis on preservation and sorting for cell therapies

  • The non-stem cellular therapies segment dominated the market in 2020 and will expand further at a steady CAGR over the forecast period. The success of CAR T therapies is one of the major driving forces of this segment

  • The pre-commercial/R&D scale segment captured the maximum revenue share in 2020 due to the increased number of research and innovation activities for new drug & therapy developments

  • North America emerged as the highest revenue-generating region in 2020 owing to the presence of a large number of approved therapies in the region influencing the market players to invest in more R&D programs

Key Topics Covered:

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Market Variables, Trends & Scope

Chapter 4. Industry Outlook

4.1 Parent Market Lineage

4.2 Ancillary Market Lineage

4.3 Market Dynamics

4.3.1 Market Driver Analysis Rising Emphasis on Regenerative Medicines and Cell Therapies Operational Superiority of Automated Systems Over Manual Processing Extensively Increasing Technological Advancements

4.3.2 Market Restraint Analysis Biological Variations Associated with Different Therapies

4.3.3 Market Opportunity Analysis Growing Fund-Raising Activities by Companies for New Technology Development Research Activitis and Product Innovations

4.3.4 Market Challenge Analysis Complicated Process of Automation

4.4 SWOT Analysis; by Factor (Political & Legal, Economic and Technological)

4.5 Porter's Five Forces Analysis

4.6 Major Deals and Strategic Alliances Analysis

4.7 COVID-19 Impact Analysis

Chapter 5. Competitive Analysis

5.1 Company Mapping

5.2 List of Potential End-users

5.3 List of Emerging Players

5.4 Market Differentiators

5.5 Competitive Dashboard Analysis

5.6 Regional Network Map

Chapter 6. Workflow Business Analysis

Chapter 7. Type Business Analysis

Chapter 8. Scale Business Analysis

8.1 Automated and Closed Cell Therapy Processing Systems Market: Scale Movement Analysis

8.2 Pre-Commercial/R&D Scale Manufacturing

8.2.1 Pre-Commercial/R&D Scale Manufacturing Market Estimates and Forecast, 2017 - 2028 (USD Million)

8.3 Commercial Scale Manufacturing

8.3.1 Commercial Scale Manufacturing Market Estimates and Forecast, 2017 - 2028 (USD Million)

Chapter 9. Regional Business Analysis

Chapter 10 Company Profiles

10.1 Strategy Framework

10.2 Market Participation Categorization

10.3 Company Profiles

For more information about this report visit

View source version on

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting